MIIP and breast carcinoma: We then analyzed the relationship between MIIP expression and the survival probability of patients with different subtype breast cancer using the UALCAN database, which showed that patients with high expression of MIIP still had a better survival probability than those with low MIIP expression in TNBC (Fig. 1H), the most malignant subtype of breast cancer, suggesting MIIP also functions as a tumor suppressor in TNBC.